Used as a key intermediate in the synthesis of carbonic anhydrase inhibitors, particularly in the development of antiglaucoma agents. Its structure enables selective binding to enzyme isoforms, making it valuable in medicinal chemistry for designing drugs that reduce intraocular pressure. Also explored for its potential in anticancer research due to sulfonamide-based enzyme inhibition properties. Shows good permeability and stability in biological systems, which supports its use in pharmaceutical formulations.